X0306 4 2014-07-30 0 0001532543 EveryWare Global, Inc. EVRY 0001120531 PRESSER STEPHEN C/O MONOMOY CAPITAL PARTNERS 142 W. 57TH ST., 17TH FL. NEW YORK NY 10019 1 0 1 0 Series A Preferred Stock 2014-07-30 4 A 0 13071.354 A 13071.354 I By Monomoy Capital Partners, L.P. Series A Preferred Stock 2014-07-30 4 A 0 406.361 A 406.361 I By MCP Supplemental Fund, L.P Series A Preferred Stock 2014-07-30 4 A 0 67.672 A 67.672 I By Monomoy Executive Co-Investment Fund, L.P. Series A Preferred Stock 2014-07-30 4 A 0 7419.617 A 7419.617 I By Monomoy Capital Partners II, L.P. Series A Preferred Stock 2014-07-30 4 A 0 234.996 A 234.996 I By MCP Supplemental Fund III, L.P. Warrants to Purchase Common Stock 0.01 2014-07-30 4 A 0 2736355 A 2021-07-30 Common Stock 2736355 2736355 I By Monomoy Capital Partners, L.P. Warrants to Purchase Common Stock 0.01 2014-07-30 4 A 0 85067 A 2021-07-30 Common Stock 85067 85067 I By MCP Supplemental Fund, L.P. Warrants to Purchase Common Stock 0.01 2014-07-30 4 A 0 14167 A 2021-07-30 Common Stock 14167 14167 I By Monomoy Executive Co-Investment Fund, L.P. Warrants to Purchase Common Stock 0.01 2014-07-30 4 A 0 1553221 A 2021-07-30 Common Stock 1553221 1553221 I By Monomoy Capital Partners II, L.P. Warrants to Purchase Common Stock 0.01 2014-07-30 4 A 0 49194 A 2021-07-30 Common Stock 49194 49194 I By MCP Supplemental Fund II, L.P. An aggregate of 20,000 shares of Series A Preferred Stock were purchased for $1,000 per share, and an additional 1,200 shares of Series A Preferred Stock were issued as a fee in connection with the transaction. These shares are held directly by Monomoy Capital Partners, L.P. ("MCP"). Monomoy General Partner, L.P. ("Monomoy GP") is the general partner of MCP, and Monomoy Ultimate GP, LLC ("Ultimate GP") is the general partner of Monomoy GP. The reporting person is a managing member of Ultimate GP. As such, the reporting person may be deemed to have an indirect pecuniary interest in the shares held directly by MCP. The reporting person expressly disclaims beneficial ownership of shares held directly by MCP, except to the extent of his pecuinary interest therein. These shares are held directly by MCP Supplemental Fund, L.P. ("MCP Supplemental Fund"). Monomoy GP is the general partner of MCP Supplemental Fund, and Ultimate GP is the general partner of Monomoy GP. The reporting person is a managing member of Ultimate GP. As such, the reporting person may be deemed to have an indirect pecuniary interest in the shares held directly by MCP Supplemental Fund. The reporting person expressly disclaims beneficial ownership of shares held directly by MCP Supplemental Fund, except to the extent of his pecuinary interest therein. These shares are held directly by Monomoy Executive Co-Investment Fund, L.P. ("Co-Investment Fund"). Monomoy GP is the general partner of Co-Investment Fund, and Ultimate GP is the general partner of Monomoy GP. The reporting person is a managing member of Ultimate GP. As such, the reporting person may be deemed to have an indirect pecuniary interest in the shares held directly by Co-Investment Fund. The reporting person expressly disclaims beneficial ownership of shares held directly by Co-Investment Fund, except to the extent of his pecuinary interest therein. These shares are held directly by Monomoy Capital Partners II, L.P. ("MCP II"). Monomoy General Partner II, L.P. ("Monomoy GP II") is the general partner of MCP II, and Ultimate GP is the general partner of Monomoy GP II. The reporting person is a managing member of Ultimate GP. As such, the reporting person may be deemed to have an indirect pecuniary interest in the shares held directly by MCP II. The reporting person expressly disclaims beneficial ownership of shares held directly by MCP II, except to the extent of his pecuinary interest therein. These shares are held directly by MCP Supplemental Fund II, L.P. ("MCP Supplemental Fund II"). Monomoy GP II is the general partner of MCP Supplemental Fund II, and Ultimate GP is the general partner of Monomoy GP II. The reporting person is a managing member of Ultimate GP. As such, the reporting person may be deemed to have an indirect pecuniary interest in the shares held directly by MCP Supplemental Fund II. The reporting person expressly disclaims beneficial ownership of shares held directly by MCP Supplemental Fund II, except to the extent of his pecuinary interest therein. Unless and until EveryWare Global, Inc. ("EveryWare") obtains any stockholder approval required by Nasdaq Listing Rule 5635 to permit full exercisability of the warrants, the number of shares of EveryWare common stock ("Common Stock") for which the warrants will be exercisable will be limited to the number of shares of Common Stock that, when taken together with all shares of Common Stock issued or issuable upon exercise of the warrants issued to lenders under the EveryWare's term loan, would be equal to 19.9% of the outstanding shares of the Common Stock as of the date of issuance of the warrants. These warrants were issued together with the shares of Series A Preferred Stock reported in Table I. /s/ Andrea Cipriani, under Power of Attorney 2014-07-31